An Israeli company was granted a license to import and commercialize medical marijuana

U.S, July 24, 2019 (MARIJUANA BUSINESS DAILY)- An Israeli company was granted a license to import and commercialize medical marijuana, marking an industry first in a country that expects cannabis exports to be an economic driver for the sector.

However, the country is yet to see its first commercial medical cannabis export, despite the approval of law about six months ago.

Tel Aviv-based Syqe Medical told Marijuana Business Daily it “has been granted a license from the Israeli Ministry of Health for the import and commercialization of medical cannabis.”

Medical cannabis from Bedrocan in the Netherlands is being used in the Syqe Inhaler, which was launched in Israel last month.While imports have occurred for research and development for years, this is thought to be the first authorized commercial import.

The inhaler, which delivers a consistent, selected, noncombustable dosage, is being sold in Israel by Teva.

The company is already looking for a local supplier, suggesting the imports may not last long.

“Syqe is in discussions with Israeli growers, and we look forward to working with them in the near future,” a company spokesperson said.

Syqe is also “exploring opportunities” with distributors and regulators to launch the product in other countries.

In a statement to MJBizDaily, the Israeli Ministry of Health noted that regulations in effect already empower the agency to approve medical cannabis imports for both research and development and commercial purposes:

“Importation of medical cannabis is possible according to the GMP and other requirements, both for research as well as medical indications.”

For years, companies in Israel have been gearing up for local and international shipments, often with investments underwritten by international players.

Lilac Mandeles, CEO of TechForCann, said some local growers were surprised by the import approval given that exports are not effectively happening yet.

“Now there is a concern among the growers from outside competition,” she said.

Local experts said there could be opportunities for international companies to meet demand in Israel.

Michael Dor, former senior medical adviser to the Israeli Ministry of Health’s Medical Cannabis Unit, said high domestic prices force some patients to the illicit market but also create “an opportunity for foreign companies to import cannabis to Israel.”

“It is very difficult to predict the governmental policy about import,” he said, “but I assume that there will be a tendency to open the market for competition, and Israeli producers will focus on new products and medications.”

Related Articles

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Want to Invest?

Cookie Policy

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read MoreCookie settingsACCEPT

Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.